These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21966755)

  • 41. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of mastodynia in postmenopausal women taking hormone therapy.
    Carranza-Lira S; Garduño-Hernández MP; Caisapanta DA; Aparicio H
    Int J Gynaecol Obstet; 2005 May; 89(2):158-9. PubMed ID: 15847887
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women.
    Long CY; Liu CM; Hsu SC; Wu CH; Wang CL; Tsai EM
    Menopause; 2006; 13(5):737-43. PubMed ID: 16946685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions.
    Guvenal T; Durna A; Erden O; Guvenal F; Cetin M; Cetin A
    Adv Ther; 2009 Aug; 26(8):805-11. PubMed ID: 19672567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
    JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
    Yasui T; Uemura H; Umino Y; Takikawa M; Kuwahara A; Saito S; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Horm Res; 2004; 61(3):117-25. PubMed ID: 14676459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mood modifications with raloxifene and continuous combined estrogen plus progestin hormone therapy.
    Carranza-Lira S; MacGregor-Gooch AL; Saráchaga-Osterwalder M
    Int J Fertil Womens Med; 2004; 49(3):120-2. PubMed ID: 15303313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S; Moaya M; Faghihzadeh S
    Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tear function changes of postmenopausal women in response to hormone replacement therapy.
    Kuscu NK; Toprak AB; Vatansever S; Koyuncu FM; Guler C
    Maturitas; 2003 Jan; 44(1):63-8. PubMed ID: 12568737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity.
    Uncu G; Avci R; Uncu Y; Kaymaz C; Develioğlu O
    Gynecol Endocrinol; 2006 Sep; 22(9):501-5. PubMed ID: 17071534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Modification of C3 and C4 levels after the administration of conjugated estrogens plus medroxiprogesterone or raloxifene in postmenopausal women].
    Carranza Lira S; MacGregor Gooch AL; Olivares A; González Legorreta SL; Saldívar N; Martínez Chéquer JC
    Ginecol Obstet Mex; 2005 Oct; 73(10):521-4. PubMed ID: 16583831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ocular changes after hormone replacement therapy in postmenopausal women. A preliminary report].
    Carranza Lira S; Jiménez AM; Olhovich I
    Ginecol Obstet Mex; 2005 Apr; 73(4):194-7. PubMed ID: 21966755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaginal dryness assessment in postmenopausal women using pH test strip.
    Carranza-Lira S; Fragoso-Díaz N; MacGregor-Gooch AL; Garduño-Hernández MP; Ríos-Calderón K; Aparicio H
    Maturitas; 2003 May; 45(1):55-8. PubMed ID: 12753944
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.